DocGo Company Leadership

DCGO Stock  USD 4.25  0.13  3.16%   
About 66 percent of all DocGo's insiders are acquiring. The analysis of insiders' sentiment of trading DocGo Inc stock suggests that quite a few insiders are confidant at this time. DocGo employs about 2.9 K people. The company is managed by 17 executives with a total tenure of roughly 6802 years, averaging almost 400.0 years of service per executive, having 171.47 employees per reported executive.

DocGo's Insider Buying Vs Selling

66

 
Selling
 
Buying

Latest Trades

2024-05-13Lee BienstockAcquired 25000 @ 3.15View
2024-03-14Michael J BurdiekAcquired 10000 @ 3.61View
2023-11-28Stephen SugrueDisposed 2859 @ 5.75View
Monitoring DocGo's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

DocGo Management Team Effectiveness

The company has return on total asset (ROA) of 0.0658 % which means that it generated a profit of $0.0658 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0941 %, meaning that it created $0.0941 on every $100 dollars invested by stockholders. DocGo's management efficiency ratios could be used to measure how well DocGo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to grow to 0.02. Also, Return On Capital Employed is likely to grow to 0.05. At this time, DocGo's Non Currrent Assets Other are very stable compared to the past year. As of the 23rd of November 2024, Other Assets is likely to grow to about 24.6 M, while Total Assets are likely to drop about 306.8 M.
As of the 23rd of November 2024, Net Income Applicable To Common Shares is likely to grow to about 41.8 M, while Common Stock Shares Outstanding is likely to drop about 101.7 M.

DocGo Workforce Comparison

DocGo Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 196,937. DocGo claims roughly 2,915 in number of employees contributing just under 2% to equities under Health Care industry.

DocGo Profit Margins

The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.260.2866
Moderately Down
Slightly volatile

DocGo Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DocGo insiders, such as employees or executives, is commonly permitted as long as it does not rely on DocGo's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DocGo insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
0.3333
1
3
 204,082 
 30,706 
2024-06-01
0.6
3
5
 45,000 
 58,828 
2024-03-01
7.0
7
1
 475,303 
 3,747 
2023-12-01
2.4286
17
7
 1,546,607 
 72,315 
2023-09-01
0.2727
3
11
 105,485 
 1,389,363 
2023-06-01
1.0909
12
11
 716,148 
 1,775,558 
2023-03-01
5.0
5
1
 379,207 
 17,530 
2022-12-01
2.75
11
4
 2,187,572 
 2,964,117 
2022-09-01
2.0
6
3
 1,749,751 
 1,078,971 
2022-03-01
0.5
1
2
 100,000 
 100,000 
2021-12-01
3.4286
24
7
 6,153,524 
 1,593,365 
2021-09-01
1.0
1
1
 2,875,000 
 2,875,000 

DocGo Notable Stakeholders

A DocGo stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DocGo often face trade-offs trying to please all of them. DocGo's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DocGo's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
James MDCEO BoardProfile
Stanley VashovskyCoFounder ChairmanProfile
Norman RosenbergTreasurer CFOProfile
Ben ShermanEVP DevelopmentProfile
Anthony CaponePresidentProfile
Ely TendlerSecretary CounselProfile
Aaron SeversChief OfficerProfile
Mike ColeVice RelationsProfile
Lee BienstockChief OfficerProfile
Andre CPAExecutive StrategyProfile
Mark MerlinLLC HoldingsProfile
Ely JDSecretary CounselProfile
Stephen SugrueChief OfficerProfile
Vrenely MunozChief OfficerProfile
Eiwe LingeforsChief OfficerProfile
Stan VashovskyChairman CoFounderProfile
Rosemarie MilanoVice ResourcesProfile

About DocGo Management Performance

The success or failure of an entity such as DocGo Inc often depends on how effective the management is. DocGo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DocGo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DocGo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.01  0.01 
Return On Equity 0.02  0.02 

DocGo Workforce Analysis

Traditionally, organizations such as DocGo use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DocGo within its industry.

DocGo Manpower Efficiency

Return on DocGo Manpower

Revenue Per Employee214.2K
Revenue Per Executive36.7M
Net Income Per Employee3.4K
Net Income Per Executive591.1K
Working Capital Per Employee57.9K
Working Capital Per Executive9.9M
When determining whether DocGo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DocGo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Docgo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Docgo Inc Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocGo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.09
Earnings Share
0.29
Revenue Per Share
6.752
Quarterly Revenue Growth
(0.26)
Return On Assets
0.0658
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.